Multidrug‐resistant tuberculous meningitis in a returned traveller

Multidrug-resistant tuberculous meningitis in a returned traveller Julie Huynh, Joel Vosu, Ben J Marais and Philip N Britton Departments of Infectious Diseases and Microbiology, and General Paediatrics, Children’s Hospital at Westmead, Discipline of Child and Adolescent Health, Children’s Hospital at Westmead and Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Sydney, New South Wales, Australia

[1]  D. Isaacs,et al.  Overview of paediatric tuberculosis cases treated in the Sydney Children's Hospitals Network, Australia. , 2019, Public health research & practice.

[2]  H. Finlayson,et al.  Clinical and Cardiac Safety of Long-term Levofloxacin in Children Treated for Multidrug-resistant Tuberculosis , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  S. M. Kadri,et al.  Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis , 2018, PLoS medicine.

[4]  H. S. Schaaf,et al.  Challenges of using new and repurposed drugs for the treatment of multidrug-resistant tuberculosis in children , 2018, Expert review of clinical pharmacology.

[5]  K. Dooley,et al.  Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant Tuberculosis , 2017, Antimicrobial Agents and Chemotherapy.

[6]  R. Stapledon,et al.  Tuberculosis notifications in Australia, 2014. , 2017, Communicable diseases intelligence quarterly report.

[7]  Yu He,et al.  Total delay in treatment among tuberculous meningitis patients in China: a retrospective cohort study , 2017, BMC Infectious Diseases.

[8]  R. Wilkinson,et al.  Standardized Methods for Enhanced Quality and Comparability of Tuberculous Meningitis Studies , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  C. Sismanidis,et al.  Global burden of drug-resistant tuberculosis in children: a mathematical modelling study. , 2016, The Lancet. Infectious diseases.

[10]  S. Swaminathan,et al.  Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Jinrong Liu,et al.  Linezolid is Associated with Improved Early Outcomes of Childhood Tuberculous Meningitis , 2016, The Pediatric infectious disease journal.

[12]  P. Goussard,et al.  Chest radiograph findings in children with tuberculous meningitis. , 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[13]  I. Bastian,et al.  Tuberculosis in Australia: bacteriologically-confirmed cases and drug resistance, 2011. A report of the Australian Mycobacterium Reference Laboratory Network. , 2014, Communicable diseases intelligence quarterly report.

[14]  A. Benedetti,et al.  Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. , 2014, The Lancet. Infectious diseases.

[15]  D. Gibb,et al.  Short Intensified Treatment in Children with Drug-susceptible Tuberculous Meningitis , 2014, The Pediatric infectious disease journal.

[16]  Ross J. Harris,et al.  Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis , 2014, BMJ : British Medical Journal.

[17]  Wenhong Zhang,et al.  Linezolid Manifests a Rapid and Dramatic Therapeutic Effect for Patients with Life-Threatening Tuberculous Meningitis , 2014, Antimicrobial Agents and Chemotherapy.

[18]  P. Dodd,et al.  Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. , 2014, The Lancet. Global health.

[19]  H. S. Schaaf,et al.  Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendations. , 2014, Tuberculosis.

[20]  C. Dye,et al.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness , 2006, The Lancet.

[21]  I. Bastian,et al.  Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2004: a report of the Australian Mycobacterium Reference Laboratory Network. , 2006, Communicable diseases intelligence quarterly report.

[22]  R. Gie,et al.  The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.